An interventional study of Community-friendly Health Recovery Program and Time-and-Attention-Matched Control Condition in HIV and Opioid Dependence, sponsored by University of Connecticut. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-02.
Sponsored by University of Connecticut · Not applicable, Interventional, and Treatment
To conduct a randomized clinical trial (RCT) of a community-friendly behavioral intervention designed to reduce HIV risk behavior among injection drug users (IDUs) in drug treatment by comparing risk-behavior outcomes of four weekly intervention sessions with a time-and-attention-matched control condition.
This research study will test the effects of CHRP, a community-friendly risk reduction intervention, which is based on the Information-Motivation-Behavioral Skills model of health behavior change (IMB; Fisher \& Fisher, 1992), and, thus, is designed to enhance knowledge, motivation, and behavior skills for reducing drug- and sex-related HIV risk behaviors. Outcomes assessed will include urine toxicology screens, self-reported HIV drug- and sex-related HIV risk behavior, HIV/AIDS knowledge, risk reduction motivation, and risk reduction behavioral skills.
To measure the effects of CHRP, the investigators are proposing a two-condition (standard of care plus the CHRP intervention vs. standard of care plus a time-and-attention matched control condition) randomized design, balancing for participant gender. The investigators will assess participants at baseline, immediately post-intervention (i.e., at 4 weeks), and at 3-, 6-, and 12-month measurement points following the intervention. This assessment approach will allow the investigators to examine the trajectory of HIV risk reduction change including the decay or emergence of intervention effects.
1,472 studies on the registry are indexed under Opioid-Related Disorders; 290 are open to participants now.
This study's enrollment of 304 is above the median of 63 across 1,166 interventional studies indexed under Opioid-Related Disorders.
Browse Opioid-Related Disorders studies →University of Connecticut is the lead sponsor of 135 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients assigned to Community-friendly Health Recovery Program (CHRP) will receive a weekly HIV risk reduction group level intervention led by two facilitators trained and supervised by the PI, a licensed clinical psychologist. The CHRP intervention is a substantially shortened version of the comprehensive Holistic Health Recovery Program (HHRP)-based interventions that have been identified as demonstrating evidence of effectiveness in two randomized clinical trials. The CHRP, which includes four 50-minute groups (1 group per week), will contain only content that relates explicitly to drug- or sex-related HIV risk reduction. Participants in both conditions will receive routine clinical services (i.e., daily methadone and case management).
Behavioral: Community-friendly Health Recovery Program
The time-and-attention-matched control condition for the proposed research will be a time and contact-matched, non-contaminating support group for individuals in recovery modeled after similar groups offered in the community. There will be no overlap between the content of the comparison intervention and experimental intervention although the basic structure will be the same. Thus, each participant will be asked to attend four 50-minute weekly group sessions led by two trained facilitators. Participants in both conditions will receive routine clinical services (i.e., daily methadone and case management).
Behavioral: Time-and-Attention-Matched Control Condition
Four weekly HIV risk-reduction groups and routine clinical services (i.e., daily methadone and case management).
Also known as: CHRP
Four weekly support groups and routine clinical services (i.e., daily methadone and case management).
Demonstrated Drug Risk Reduction Skills (0-100%)
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
Time frame: Baseline
Demonstrated Drug Risk Reduction Skills (0-100%)
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
Time frame: Immediately Post-Intervention, at 4 weeks
Demonstrated Drug Risk Reduction Skills (0-100%)
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
Time frame: 3-month follow up
Demonstrated Drug Risk Reduction Skills (0-100%)
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
Time frame: 6-month follow up
Demonstrated Drug Risk Reduction Skills (0-100%)
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
Time frame: 12-month follow up
Safer Drug Use (0-4)
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use.
Time frame: Baseline
Safer Drug Use (0-4)
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use.
Time frame: Immediately Post-Intervention, at 4 weeks
Safer Drug Use (0-4)
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use.
Time frame: 3-month follow up
Safer Drug Use (0-4)
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use.
Time frame: 6-month follow up
Safer Drug Use (0-4)
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use.
Time frame: 12-month follow up
Drug-related HIV-risk Reduction Knowledge (0-1)
Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge).
Time frame: Baseline
Drug-related HIV-risk Reduction Knowledge (0-1)
Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge).
Time frame: Immediately Post-Intervention, at 4 weeks
Drug-related HIV-risk Reduction Knowledge (0-1)
Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge).
Time frame: 3-month follow up
Drug-related HIV-risk Reduction Knowledge (0-1)
Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge).
Time frame: 6-month follow up
Drug-related HIV-risk Reduction Knowledge (0-1)
Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles").
Time frame: 12-month follow up
Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior.
Time frame: Baseline
Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior.
Time frame: Immediately Post-Intervention, at 4 weeks
Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior.
Time frame: 3-month follow up
Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior.
Time frame: 6-month follow up
Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior.
Time frame: 12-month follow up
Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: Baseline
Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: Immediately Post-Intervention, at 4 weeks
Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: 3-month follow up
Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: 6-month follow up
Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: 12-month follow up
Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior.
Time frame: Baseline
Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior.
Time frame: Immediately Post-Intervention, at 4 weeks
Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior.
Time frame: 3-month follow up
Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior.
Time frame: 6-month follow up
Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior.
Time frame: 12-month follow up
Female Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica.
Time frame: Baseline
Female Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica.
Time frame: Immediately Post-Intervention, at 4 weeks
Female Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica.
Time frame: 3-month follow up
Female Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica.
Time frame: 6-month follow up
Female Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica.
Time frame: 12-month follow up
Male Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica.
Time frame: Baseline
Male Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica.
Time frame: Immediately Post-Intervention, at 4 weeks
Male Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica.
Time frame: 3-month follow up
Male Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica.
Time frame: 6-month follow up
Male Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica.
Time frame: 12-month follow up
Condom Use (0-4)
Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use.
Time frame: Baseline
Condom Use (0-4)
Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use.
Time frame: Immediately Post-Intervention, at 4 weeks
Condom Use (0-4)
Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use.
Time frame: 3-month follow up
Condom Use (0-4)
Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use.
Time frame: 6-month follow up
Condom Use (0-4)
Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use.
Time frame: 12-month follow up
Sex-related HIV-risk Reduction Knowledge (0-1)
Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge.
Time frame: Baseline
Sex-related HIV-risk Reduction Knowledge (0-1)
Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge.
Time frame: Immediately Post-Intervention, at 4 weeks
Sex-related HIV-risk Reduction Knowledge (0-1)
Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge.
Time frame: 3-month follow up
Sex-related HIV-risk Reduction Knowledge (0-1)
Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge.
Time frame: 6-month follow up
Sex-related HIV-risk Reduction Knowledge (0-1)
Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge.
Time frame: 12-month follow up
Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior.
Time frame: Baseline
Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior.
Time frame: Immediately Post-Intervention, at 4 weeks
Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior.
Time frame: 3-month follow up
Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior.
Time frame: 6-month follow up
Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior.
Time frame: 12-month follow up
Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: Baseline
Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: Immediately Post-Intervention, at 4 weeks
Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: 3-month follow up
Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: 6-month follow up
Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: 12-month follow up
Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior.
Time frame: Baseline
Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior.
Time frame: Immediately Post-Intervention, at 4 weeks
Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior.
Time frame: 3-month follow up
Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior.
Time frame: 6-month follow up
Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior.
Time frame: 12-month follow up
A total of 648 participants were screened from March 2007 through August 2010 from a methadone maintenance program in New Haven, Connecticut.
| Milestone | CHRP Group | Control Condition |
|---|---|---|
| Started | 149 | 155 |
| Completed | 149 | 155 |
| Not completed | 0 | 0 |
| Milestone | CHRP Group | Control Condition |
|---|---|---|
| Started | 149 | 155 |
| Completed | 135 | 141 |
| Not completed | 14 | 14 |
| Milestone | CHRP Group | Control Condition |
|---|---|---|
| Started | 135 | 141 |
| Completed | 129 | 119 |
| Not completed | 6 | 22 |
| Milestone | CHRP Group | Control Condition |
|---|---|---|
| Started | 129 | 119 |
| Completed | 114 | 111 |
| Not completed | 15 | 8 |
| Milestone | CHRP Group | Control Condition |
|---|---|---|
| Started | 114 | 111 |
| Completed | 111 | 109 |
| Not completed | 3 | 2 |
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
| Percentage of correct steps | CHRP Group | Control Condition |
|---|---|---|
| Demonstrated Drug Risk Reduction Skills (0-100%) | 40.60 ± 1.99 | 42.75 ± 2.09 |
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
| Percentage of correct steps | CHRP Group | Control Condition |
|---|---|---|
| Demonstrated Drug Risk Reduction Skills (0-100%) | 76.37 ± 2.03 | 53.11 ± 2.14 |
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
| Percentage of correct steps | CHRP Group | Control Condition |
|---|---|---|
| Demonstrated Drug Risk Reduction Skills (0-100%) | 69.59 ± 2.04 | 60.34 ± 2.15 |
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
| Percentage of correct steps | CHRP Group | Control Condition |
|---|---|---|
| Demonstrated Drug Risk Reduction Skills (0-100%) | 74.12 ± 1.97 | 63.12 ± 2.07 |
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
| Percentage of correct steps | CHRP Group | Control Condition |
|---|---|---|
| Demonstrated Drug Risk Reduction Skills (0-100%) | 72.61 ± 1.91 | 63.63 ± 2.01 |
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Safer Drug Use (0-4) | 3.25 ± 0.10 | 3.39 ± 0.10 |
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Safer Drug Use (0-4) | 3.78 ± 0.06 | 3.79 ± 0.06 |
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Safer Drug Use (0-4) | 3.83 ± 0.05 | 3.81 ± 0.05 |
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Safer Drug Use (0-4) | 3.84 ± 0.05 | 3.77 ± 0.05 |
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Safer Drug Use (0-4) | 3.87 ± 0.05 | 3.85 ± 0.05 |
Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge).
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Drug-related HIV-risk Reduction Knowledge (0-1) | 0.96 ± 0.02 | 1.00 ± 0.02 |
Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge).
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Drug-related HIV-risk Reduction Knowledge (0-1) | 1.00 ± 0.01 | 0.98 ± 0.01 |
Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge).
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Drug-related HIV-risk Reduction Knowledge (0-1) | 1.00 ± 0.01 | 0.96 ± 0.01 |
Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge).
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Drug-related HIV-risk Reduction Knowledge (0-1) | 0.96 ± 0.02 | 0.99 ± 0.02 |
Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles").
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Drug-related HIV-risk Reduction Knowledge (0-1) | 0.98 ± 0.02 | 0.96 ± 0.02 |
Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.79 ± 0.05 | 4.85 ± 0.05 |
Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.91 ± 0.05 | 4.83 ± 0.05 |
Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.87 ± 0.06 | 4.86 ± 0.07 |
Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.87 ± 0.06 | 4.78 ± 0.06 |
Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.88 ± 0.04 | 4.92 ± 0.04 |
Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.65 ± 0.08 | 4.72 ± 0.09 |
Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.77 ± 0.08 | 4.69 ± 0.08 |
Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.90 ± 0.04 | 4.85 ± 0.05 |
Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.73 ± 0.07 | 4.91 ± 0.07 |
Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.63 ± 0.09 | 4.75 ± 0.09 |
Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.01 ± 0.10 | 4.00 ± 0.11 |
Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.41 ± 0.05 | 4.38 ± 0.09 |
Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.42 ± 0.08 | 4.36 ± 0.09 |
Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.22 ± 0.09 | 4.45 ± 0.10 |
Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.38 ± 0.08 | 4.52 ± 0.08 |
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica.
| percentage of correct steps | CHRP Group | Control Condition |
|---|---|---|
| Female Condom Skills (0-100%) | 57.60 ± 1.69 | 59.38 ± 1.78 |
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica.
| percentage of correct steps | CHRP Group | Control Condition |
|---|---|---|
| Female Condom Skills (0-100%) | 82.54 ± 1.25 | 74.32 ± 1.31 |
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica.
| percentage of correct steps | CHRP Group | Control Condition |
|---|---|---|
| Female Condom Skills (0-100%) | 79.29 ± 1.38 | 79.07 ± 1.45 |
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica.
| percentage of correct steps | CHRP Group | Control Condition |
|---|---|---|
| Female Condom Skills (0-100%) | 83.03 ± 1.19 | 80.86 ± 1.26 |
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica.
| percentage of correct steps | CHRP Group | Control Condition |
|---|---|---|
| Female Condom Skills (0-100%) | 83.37 ± 1.19 | 82.19 ± 1.25 |
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica.
| percentage of correct steps | CHRP Group | Control Condition |
|---|---|---|
| Male Condom Skills (0-100%) | 71.63 ± 1.35 | 73.97 ± 1.42 |
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica.
| percentage of correct steps | CHRP Group | Control Condition |
|---|---|---|
| Male Condom Skills (0-100%) | 87.23 ± 1.40 | 82.71 ± 1.47 |
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica.
| percentage of correct steps | CHRP Group | Control Condition |
|---|---|---|
| Male Condom Skills (0-100%) | 85.01 ± 1.22 | 84.64 ± 1.28 |
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica.
| percentage of correct steps | CHRP Group | Control Condition |
|---|---|---|
| Male Condom Skills (0-100%) | 87.51 ± 1.04 | 87.64 ± 1.09 |
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica.
| percentage of correct steps | CHRP Group | Control Condition |
|---|---|---|
| Male Condom Skills (0-100%) | 86.70 ± 1.17 | 85.95 ± 1.24 |
Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Condom Use (0-4) | 3.80 ± 0.24 | 3.56 ± 0.26 |
Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Condom Use (0-4) | 3.61 ± 0.24 | 3.56 ± 0.26 |
Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Condom Use (0-4) | 3.95 ± 0.24 | 3.75 ± 0.25 |
Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Condom Use (0-4) | 3.65 ± 0.24 | 3.79 ± 0.25 |
Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Condom Use (0-4) | 3.73 ± 0.24 | 3.83 ± 0.25 |
Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Sex-related HIV-risk Reduction Knowledge (0-1) | 0.87 ± 0.03 | 0.91 ± 0.03 |
Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Sex-related HIV-risk Reduction Knowledge (0-1) | 1.00 ± 0.02 | 0.95 ± 0.02 |
Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Sex-related HIV-risk Reduction Knowledge (0-1) | 0.97 ± 0.02 | 0.93 ± 0.02 |
Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Sex-related HIV-risk Reduction Knowledge (0-1) | 0.97 ± 0.02 | 0.95 ± 0.02 |
Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Sex-related HIV-risk Reduction Knowledge (0-1) | 0.98 ± 0.01 | 0.99 ± 0.01 |
Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.20 ± 0.09 | 4.26 ± 0.09 |
Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.41 ± 0.08 | 4.24 ± 0.08 |
Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.39 ± 0.08 | 4.24 ± 0.09 |
Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.40 ± 0.08 | 4.29 ± 0.08 |
Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.21 ± 0.09 | 4.22 ± 0.09 |
Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.67 ± 0.07 | 4.81 ± 0.08 |
Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.73 ± 0.07 | 4.75 ± 0.07 |
Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.73 ± 0.07 | 4.71 ± 0.07 |
Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.75 ± 0.07 | 4.77 ± 0.07 |
Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.57 ± 0.08 | 4.70 ± 0.08 |
Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | 3.00 ± 0.12 | 3.09 ± 0.13 |
Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | 2.99 ± 0.12 | 3.06 ± 0.13 |
Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | 3.02 ± 0.12 | 3.14 ± 0.12 |
Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.75 ± 0.07 | 4.77 ± 0.07 |
Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior.
| units on a scale | CHRP Group | Control Condition |
|---|---|---|
| Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.57 ± 0.08 | 4.70 ± 0.08 |
Collected over March 2007 through August 2011.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| CHRP Group | — | 0/149 (0%) | 0/149 (0%) |
| Control Condition | — | 0/155 (0%) | 0/155 (0%) |
| Age, Categorical(Participants) | CHRP Group | Control Condition | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 149 | 155 | 304 |
| >=65 years | 0 | 0 | 0 |
| Age, Continuous(years) | CHRP Group | Control Condition | Total |
|---|---|---|---|
| Mean | 34.26 ± 9.939 | 33.50 ± 9.141 | 33.87 ± 9.532 |
| Sex: Female, Male(Participants) | CHRP Group | Control Condition | Total |
|---|---|---|---|
| Female | 76 | 81 | 157 |
| Male | 73 | 74 | 147 |
| Region of Enrollment(participants) | CHRP Group | Control Condition | Total |
|---|---|---|---|
| United States | 149 | 155 | 304 |
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.